US Patent Issued to AVIDITY BIOSCIENCES on Dec. 9 for "Compositions and methods of using PRKAG2-targeting antibody-oligonucleotide conjugates" (California Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,257, issued on Dec. 9, was assigned to AVIDITY BIOSCIENCES INC. (San Diego).

"Compositions and methods of using PRKAG2-targeting antibody-oligonucleotide conjugates" was invented by Maria Azzurra Missinato (San Diego), Georgios Karamanlidis (Thousand Oaks, Calif.), Sami Abdulwahab Abdulkadir (San Diego), Subbarao Nallagatla (San Diego) and Maryam Jordan (Escondido, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods of use for PRKAG2 antibody oligonucleotide conjugates (AOC)."

The patent was filed on June 26, 2024, under Application No. 18/755,579.

*For furt...